Prepare for your visit

Sandra Rajan

Optometrist · Sugar Land, TX · NPI 1427544006

One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.

What was reported

$3,282.55

in general payments reported to CMS, 2019-2025

Who reported paying

General payments only, top 6 by amount.

Bausch & Lomb, A Division of Bausch Health US, LLC $1,390.66
Johnson & Johnson Vision Care, INC. $253.20
Dompe US, INC. $245.82
Sun Pharmaceutical Industries INC. $233.61
Novartis Pharmaceuticals Corporation $212.09
Bausch & Lomb Americas INC. $208.19

Drugs and devices associated with these payments

Oxervate Miebo Cirrus Hd-Oct Acuvue Xiidra Cequa

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

I saw Sandra Rajan listed in the CMS Open Payments database. Can you tell me about your work with those companies?
Is there a generic or alternative to this medication, and would it work as well for me?
What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.

Notes

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.

GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/5677020/sandra-rajan